| Samira Shojaee, MD | |
|
3601 The Vanderbilt Clinic, Nashville, TN 37232-5051 | |
| (615) 936-2000 | |
| Not Available |
| Full Name | Samira Shojaee |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Allergy & Immunology |
| Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497937668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0101251136 (Virginia) | Secondary |
| 207RA0201X | Internal Medicine - Allergy & Immunology | 65653 (Tennessee) | Primary |
| Entity Name | Vanderbilt University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
Science Applications International Corporation announced today it was awarded a follow-on contract by the U.S. Army Medical Research and Materiel Command (USAMRMC) to provide scientific and other support services to the Congressionally Directed Medical Research Programs.
Tumors that are about to progress and metastasize go through a process also seen in normal embryonic development, known as the epithelial to mesenchymal transition (EMT).
Boston University School of Medicine's researchers have found that sociodemographic characteristics are related to a patients' willingness to participate in cancer screenings. They found this was more important than both attitudinal barriers and medical facilitors. This study appears in the March issue of the Journal of the National Medical Association.
Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samira Shojaee, MD 3841 Green Hills Village Dr, Nashville, TN 37215-2691 Ph: () - | Samira Shojaee, MD 3601 The Vanderbilt Clinic, Nashville, TN 37232-5051 Ph: (615) 936-2000 |
News Archive
Science Applications International Corporation announced today it was awarded a follow-on contract by the U.S. Army Medical Research and Materiel Command (USAMRMC) to provide scientific and other support services to the Congressionally Directed Medical Research Programs.
Tumors that are about to progress and metastasize go through a process also seen in normal embryonic development, known as the epithelial to mesenchymal transition (EMT).
Boston University School of Medicine's researchers have found that sociodemographic characteristics are related to a patients' willingness to participate in cancer screenings. They found this was more important than both attitudinal barriers and medical facilitors. This study appears in the March issue of the Journal of the National Medical Association.
Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.
› Verified 6 days ago
Megan Desai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Internal Medicine Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Dr. Evan Zehr, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1161 21st Ave S, Nashville, TN 37232 Phone: 615-322-6943 | |
Spurthi N Bhatt, MD MPH Internal Medicine Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 |